Alzinova in Biostock Article

Date: 2022-01-28

Check out this article (in Swedish) by BioStock - Connecting Innovation and Capital featuring an interview with our Chief Scientific Officer, Anders Sandberg, who provides details about the the humanisation of and lead candidate selection for our monoclonal antibody, ALZ-201.

“Alzinova stärker finanserna och utser Alzheimerkandidat”

Read the article (in Swedish)